Akorn, Inc.  

(Public, NASDAQ:AKRX)   Watch this stock  
Find more results for Brian Salt
22.81
+0.10 (0.44%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 22.28 - 23.16
52 week 12.85 - 28.00
Open 22.75
Vol / Avg. 674,475.00/928,268.00
Mkt cap 2.20B
P/E 49.72
Div/yield     -
EPS 0.46
Shares 96.65M
Beta 0.27
Inst. own 84%
May 6, 2014
Q1 2014 Akorn, Inc. Earnings Conference Call - 10:00AM EDT - Add to calendar
May 6, 2014
Q1 2014 Akorn, Inc. Earnings Release - 9:30AM EDT - Add to calendar
May 2, 2014
Akorn, Inc. Annual Shareholder Meeting - 11:00AM EDT - Add to calendar
Mar 3, 2014
Q4 2013 Akorn, Inc. Earnings Conference Call
Mar 3, 2014
Q4 2013 Akorn, Inc. Earnings Release
Feb 12, 2014
Akorn, Inc. at Leerink Swann Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 19.63% 16.48%
Operating margin 29.64% 27.76%
EBITD margin - 33.24%
Return on average assets 15.90% 13.07%
Return on average equity 26.81% 22.70%
Employees 786 -
CDP Score - -

Address

Suite 300 1925 W. Field Court
LAKE FOREST, IL 60045
United States - Map
+1-847-2796100 (Phone)
+1-800-9433694 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Akorn, Inc. is a manufacturer and markets a full line of diagnostic and therapeutic ophthalmic pharmaceuticals, as well as niche hospital drugs and injectable pharmaceuticals. The Company operates in three segments: ophthalmic, hospital drugs & injectables, and contract services. The Company operates pharmaceutical manufacturing plants in the United States at Decatur, Illinois and Somerset, New Jersey, and internationally at Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, R&D centers in Skokie and Vernon Hills, Illinois and corporate offices in Lake Forest, Illinois. The Company�s customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, retail pharmacy chains and other pharmaceutical companies. In April 2014, the Company acquired Hi-Tech Pharmacal Co., Inc.

Officers and directors

John N. Kapoor Ph.D. Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Rajat Rai Chief Executive Officer
Age: 46
Bio & Compensation  - Reuters
Timothy A. Dick Chief Financial Officer
Age: 43
Bio & Compensation  - Reuters
Bruce Kutinsky Chief Operating Officer
Age: 47
Bio & Compensation  - Reuters
Mark M. Silverberg Executive Vice President - Global Quality Assurance and Alliance Management
Age: 59
Bio & Compensation  - Reuters
Joseph P. Bonaccorsi Senior Vice President, General Counsel, Secretary
Age: 48
Bio & Compensation  - Reuters
John R. Sabat Senior Vice President - National Accounts and Trade Relations
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brian Tambi Director
Age: 67
Bio & Compensation  - Reuters
Kenneth S. Abramowitz Independent Director
Age: 62
Bio & Compensation  - Reuters
Adrienne L. Graves Ph.D. Independent Director
Age: 59
Bio & Compensation  - Reuters